Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
Phase 1 Completed
29 enrolled
Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer
Completed
57 enrolled
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Phase 2 Completed
40 enrolled 20 charts
Priming Immunotherapy in Advanced Disease With Radiation
Phase 2 Completed
76 enrolled 9 charts
KEYNOTE-412
Phase 3 Completed
804 enrolled 20 charts
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
Phase 2 Completed
26 enrolled 13 charts
Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
Phase 2 Completed
40 enrolled 14 charts
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
Phase 1 Completed
9 enrolled
Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
Phase 2 Completed
160 enrolled
UPFRONT-NECK
Phase 3 Completed
65 enrolled
AACER
Phase 2 Completed
53 enrolled
REPORT
Phase 1/2 Completed
20 enrolled
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Phase 2 Completed
91 enrolled 11 charts
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Phase 1 Completed
41 enrolled
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Phase 1 Completed
13 enrolled
NICO
Phase 2 Completed
21 enrolled
sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC
Phase 1 Completed
3 enrolled
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
Phase 2 Completed
31 enrolled 8 charts
Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Phase 2 Completed
46 enrolled
Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer
Phase 2 Completed
40 enrolled 69 charts
Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma
Phase NA Completed
84 enrolled
PREVLAR
Phase 2 Completed
53 enrolled 15 charts
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Phase 2 Completed
30 enrolled
OPTIMA
Phase 2 Completed
62 enrolled 13 charts
WISTERIA
Phase 1 Completed
9 enrolled
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
RT-CASinHNC
Completed
907 enrolled
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Phase 1 Completed
48 enrolled
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
Phase 2 Completed
16 enrolled 12 charts
Risk for Subsequent Osteoradionecrosis in A Transferred Fibula Flap in Head and Neck Cancer Patients Undergoing Segmental Mandibulectomy: a Cohort Study
Completed
580 enrolled
The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)
Phase NA Completed
112 enrolled 11 charts
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
24 enrolled 11 charts
ASOG-HNO1
Phase NA Completed
51 enrolled
DURTRE-RAD
Phase 2 Completed
18 enrolled
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Phase 1 Completed
50 enrolled
Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer
Phase 2 Completed
74 enrolled 8 charts
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
69 enrolled 7 charts
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Phase 2 Completed
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
Phase 1/2 Completed
24 enrolled 12 charts
G-DEFINER
Completed
247 enrolled
BMX-HN
Phase 1/2 Completed
29 enrolled 14 charts
PembroRad
Phase 2 Completed
133 enrolled
Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution
Phase NA Completed
21 enrolled
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Phase 1 Completed
20 enrolled
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Phase 3 Completed
111 enrolled 11 charts
IT-MATTERS
Phase 3 Completed
928 enrolled 25 charts
Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial
Phase NA Completed
144 enrolled
CisFRad
Phase 2 Completed
124 enrolled
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Phase 3 Completed
209 enrolled
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Phase 1/2 Completed
53 enrolled